Načítá se...
Glioblastoma Treatment in the Elderly
Although current treatment advances prolong patient survival, treatment for glioblastoma (GBM) in the elderly has become an emerging issue. The definition of “elderly” differs across articles; GBM predominantly occurs at an age ≥65 years, and the prognosis worsens with increasing age. Regarding mole...
Uloženo v:
| Vydáno v: | Neurol Med Chir (Tokyo) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Japan Neurosurgical Society
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5735230/ https://ncbi.nlm.nih.gov/pubmed/29081442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2176/nmc.ra.2017-0009 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|